colorectal cancer
Chi-Med’s fruquintinib gets approval for colorectal cancer in China
Hutchison China MediTech (Chi-Med) has secured approval from the National Medical Products Administration of China (NMPA) for the use of…
Array BioPharma’s mCRC therapy gets breakthrough status
Array BioPharma has received breakthrough therapy designation from the US Food and Drug Administration (FDA) to use encorafenib (Braftovi) in…
